Eurofarma
Walker Lahmann is an accomplished Executive Director with extensive experience in the pharmaceutical industry, currently serving at Eurofarma since May 2014. Previously, Walker held the position of Executive Director at Hypermarcas S/A from May 2008 to February 2014, managing a diverse team and overseeing a substantial US$ 1 billion portfolio. Earlier roles include Marketing Manager at Medley Indústria Farmacêutica S/A and Group Product Manager at Servier, with a focus on various therapeutic areas. Walker's educational background includes an MBA from The Wharton School, a second MBA from Fundação Dom Cabral, and medical degrees with a specialization in Ophthalmology from Santa Casa de Misericórdia do Rio de Janeiro and Universidade Gama Filho, alongside a Doctor of Medicine degree from Universidade Federal de Minas Gerais.
This person is not in any teams
This person is not in any offices
Eurofarma
5 followers
Since its establishment in 1972, Eurofarma has been operating in the health industry, producing and marketing products and services to improve people's quality of life. Focused on generating shared value, it operates in the areas of Prescription, Nos-Prescription, Generics, Hospital and Oncology. It offers over 700 products, over 2,000 SKUs and serves 42 medical specialties. In Brazil, it covers 100 therapeutic classes, which represent 70% of prescriptions in the entire market. Operating in 20 countries, with manufacturing facilities in Brazil and industrial parks in six other Latin American countries, it generated net sales of R$ 7.1 billion in 2021, a growth of 23% compared to the previous year, and employs more than 8,100 people.